Investors

AstraZeneca Canada Inc. is a wholly owned indirect subsidiary of AstraZeneca PLC with global headquarters in London, England. Shares of AstraZeneca PLC are traded publicly on the New York Stock Exchange, London Stock Exchange and Stockholm Stock Exchange under the symbol ‘AZN’.

To view or print an electronic version of our annual report, or for more detailed information including current stock prices and additional financial information, please visit our international finance web page.